Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 8 | 16 | 1 | — | 29 |
Lymphoma | D008223 | — | C85.9 | 7 | 12 | 11 | 1 | 1 | 28 |
Follicular lymphoma | D008224 | — | C82 | 2 | 2 | 2 | 1 | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 3 | 7 | 8 | — | 1 | 17 |
B-cell lymphoma | D016393 | — | — | 5 | 7 | 7 | — | 1 | 16 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 5 | 4 | — | 1 | 12 |
Triple negative breast neoplasms | D064726 | — | — | 3 | 3 | 3 | — | — | 9 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | — | 4 | — | — | 4 |
Recurrence | D012008 | — | — | — | — | 3 | — | — | 3 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | — | 3 | — | — | 3 |
Inflammatory breast neoplasms | D058922 | — | — | — | — | 2 | — | — | 2 |
Mucinous adenocarcinoma | D002288 | — | — | — | — | 1 | — | — | 1 |
Ductal carcinoma breast | D018270 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Uterine cervical neoplasms | D002583 | — | — | — | 1 | — | — | — | 1 |
Mantle-cell lymphoma | D020522 | — | C83.1 | — | 1 | — | — | — | 1 |
Immunoblastic lymphadenopathy | D007119 | EFO_1001350 | C86.5 | — | 1 | — | — | — | 1 |
Aids-related lymphoma | D016483 | EFO_1001365 | — | — | 1 | — | — | — | 1 |
Reactive arthritis | D016918 | EFO_0007460 | M02.3 | — | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | — | 1 | — | — | — | 1 |
Drug common name | — |
INN | — |
Description | — |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | — |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |